The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The global Polio Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 949.9 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.
This report aims to provide a comprehensive presentation of the global market for Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccine.
Report Scope
The Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polio Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
Segment by Type
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
Segment by Application
- Public
- Private
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polio Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Polio Vaccine Market Overview
1.1 Product Overview and Scope of Polio Vaccine
1.2 Polio Vaccine Segment by Type
1.2.1 Global Polio Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Segment by Application
1.3.1 Global Polio Vaccine Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Polio Vaccine Revenue 2019-2030
1.4.2 Global Polio Vaccine Sales 2019-2030
1.4.3 Global Polio Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Polio Vaccine Market Competition by Manufacturers
2.1 Global Polio Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Polio Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Polio Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polio Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polio Vaccine, Product Type & Application
2.7 Polio Vaccine Market Competitive Situation and Trends
2.7.1 Polio Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polio Vaccine Players Market Share by Revenue
2.7.3 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polio Vaccine Retrospective Market Scenario by Region
3.1 Global Polio Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Polio Vaccine Global Polio Vaccine Sales by Region: 2019-2030
3.2.1 Global Polio Vaccine Sales by Region: 2019-2024
3.2.2 Global Polio Vaccine Sales by Region: 2025-2030
3.3 Global Polio Vaccine Global Polio Vaccine Revenue by Region: 2019-2030
3.3.1 Global Polio Vaccine Revenue by Region: 2019-2024
3.3.2 Global Polio Vaccine Revenue by Region: 2025-2030
3.4 North America Polio Vaccine Market Facts & Figures by Country
3.4.1 North America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Polio Vaccine Sales by Country (2019-2030)
3.4.3 North America Polio Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polio Vaccine Market Facts & Figures by Country
3.5.1 Europe Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Polio Vaccine Sales by Country (2019-2030)
3.5.3 Europe Polio Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polio Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Polio Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Polio Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Polio Vaccine Market Facts & Figures by Country
3.7.1 Latin America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Polio Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Polio Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Polio Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Polio Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Polio Vaccine Sales by Type (2019-2030)
4.1.1 Global Polio Vaccine Sales by Type (2019-2024)
4.1.2 Global Polio Vaccine Sales by Type (2025-2030)
4.1.3 Global Polio Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Polio Vaccine Revenue by Type (2019-2030)
4.2.1 Global Polio Vaccine Revenue by Type (2019-2024)
4.2.2 Global Polio Vaccine Revenue by Type (2025-2030)
4.2.3 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Polio Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Polio Vaccine Sales by Application (2019-2030)
5.1.1 Global Polio Vaccine Sales by Application (2019-2024)
5.1.2 Global Polio Vaccine Sales by Application (2025-2030)
5.1.3 Global Polio Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Polio Vaccine Revenue by Application (2019-2030)
5.2.1 Global Polio Vaccine Revenue by Application (2019-2024)
5.2.2 Global Polio Vaccine Revenue by Application (2025-2030)
5.2.3 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Polio Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IMBCA Polio Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Polio Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polio Vaccine Industry Chain Analysis
7.2 Polio Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polio Vaccine Production Mode & Process
7.4 Polio Vaccine Sales and Marketing
7.4.1 Polio Vaccine Sales Channels
7.4.2 Polio Vaccine Distributors
7.5 Polio Vaccine Customers
8 Polio Vaccine Market Dynamics
8.1 Polio Vaccine Industry Trends
8.2 Polio Vaccine Market Drivers
8.3 Polio Vaccine Market Challenges
8.4 Polio Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
